videobanner
Race Against Time To Protect Life Safety

Achieve full-process on-site detection within 30 minutes

Announcement

The company’s English name has changed from “Jiangsu Qitian Gene Biotechnology Co., Ltd.” to “QT Biotech Co., Ltd.”

The Pacesetter In On-site Molecular Detection

Our vision is to be the pacesetter in on-site molecular detection, and to lead the development of the industry through superior R&D strength and innovation ability and make contributions to the protection of human life and safety

RAA Full-Industrial Chain Supplier

Enzyme raw material platform, reagent platform, and instrument platform

scroll down

Cutting-Edge Technology 

Recombinase Aided Amplification Technology

Recombinase Aided Amplification (RAA) technology uses recombinase, single-stranded binding protein, and DNA polymerase under isothermal conditions (37–42℃) to amplify nucleic acids.
RAA overcomes the limitations of traditional PCR that relies on thermal cycling, offering advantages such as isothermal amplification, superior efficiency, high sensitivity and specificity, and user-friendly operation.
RAA aids QT BIO in developing a “more accurate, faster, and more convenient” biosecurity prevention and control system, in advancing molecular detection technologies, in building a comprehensive industry chain for biological prevention and control products, and in leading the upgrade of nucleic acid amplification technology towards “on-site detection and deskilling”.

VIEW MORE
QT BIO
video

Core Platform

Raw Material

Raw Material

M-MLV Reverse Transcriptase & RAA/RT-RAA Enzyme Freeze-Dried Pellet (Fluorescent Method)

 

VIEW MORE →
Qitian

Raw Material

Reagent

Reagent

Reagents include extraction reagents, research reagents and detection reagents

VIEW MORE →
Qitian

Reagent

Instrument

Instrument

Based on RAA technology, the instrument features rapid isothermal amplification, compact and portable design, smart analysis, and easy operation.

VIEW MORE →
Qitian

Instrument

Application Field

News

The original company name, “Jiangsu Qitian Gene Biotechnology Co., Ltd.” is nowofficially changed to “QT Biotech Co., Ltd.”, with the abbreviation “QT BIO”. Thetransition period for this name change will commence on December 1, 2024, andconclude on December 31, 2024, During this period, we will gradually carry out thename change process, including but not limited to company logos, promotionalmaterials and contract documents.

2026-03-12

Literature sharing: Bursaphelenchus xylophilus detection by RAA-powered CRISPR-based diagnostics

Pine wilt disease (PWD) causes significant ecological and economic damage globally. Early detection of pine wood nematode (PWN), Bursaphelenchus xylophilus, the main causal agent of PWD, is critical for disease management.

2026-01-29

Literature Sharing: A Novel Duplex RT-RAA Method for Rapid and Accurate Detection of Respiratory Syncytial Virus (RSV)

Respiratory syncytial virus (RSV) is the leading pathogen causing lower respiratory tract infections (such as pneumonia and bronchitis) in infants and young children worldwide, with no specific vaccines or antiviral drugs currently available.

2026-01-15

PCR VS RAA

With the growing demand for precision medicine, nucleic acid detection technology continues to evolve. Based on technical principles and application scenarios, this article systematically analyzes the core differences between PCR and RAA, with a focus on the innovative value of RAA technology.

Authoritative Collaboration

China CDC

China CDC

General Administration of Customs of the People's Republic of China

General Administration of Customs of the People's Republic of China

China Animal Health and Epidemiology Center

China Animal Health and Epidemiology Center

Jiangsu Institute of Parasitic Diseases

Jiangsu Institute of Parasitic Diseases

Leipzig University

Leipzig University

Race against Time to Protect Life Safety

Copyright © 2025 QT Biotech Co., Ltd.
苏ICP备2025209101号-1

营业执照